A single-blind, sham procedure randomised trial of transcatheter bariatric embolotherapy (TBE) of the left gastric artery (LGA) in patients with obesity has shown that the procedure is well-tolerated and resulted in effective weight loss at six-month follow-up, compared with the sham control, and the weight loss was sustained at 12 months.
Providing support to help people with prediabetes make small changes to their lifestyle, diet and physical activity can almost halve the risk of developing type 2 diabetes, according the results of the Norfolk Diabetes Prevention Study (NDPS) the largest diabetes prevention research study in the world in the last 30 years.
Allurion Technologies has announced new clinical data from two studies on the Elipse Balloon at ObesityWeek 2020. The Allurion Program features the Elipse Balloon, the world’s first and only procedureless weight loss device. The balloon is designed to remain in the stomach for four months and is paired with a Bluetooth connected scale and Allurion smartphone app and a supervised nutritional programme.
The LINX Reflux Management System provides effective long-term control of gastroesophageal reflux disease (GERD) and eliminates the need for daily reflux medications in 79% of patients according to the study, ‘Six to 12-year outcomes of magnetic sphincter augmentation (MSA) for gastroesophageal reflux disease’, published in the journal Nature Scientific Reports.
On 29th September 2020, the International Bariatric Club (IBC) hosted the 16th iteration in its series of IBC ‘Oxford Hot Topics in Surgery’ webinars, entitled ‘Banded sleeve gastrectomy - Is there a method to this madness?’. The webinar featured presentations from world renowned experts in banded sleeve gastrectomy including Professors Phil Schauer (USA) and Jodok Fink (Germany), and Dr Paolo Gentileschi (Italy), as well as a video presentation by Dr Mohit Bhandari (India).
The standard approach of assessing long-term risk for atherosclerotic cardiovascular disease (ASCVD) works just as well for patients who are overweight as they do for patients at an optimal weight, according to a study by researchers from Yale and published in the JAMA Network Open.
Kidney transplants are frequently denied to patients with obesity, partly due to an increased risk of surgical complications, particularly infections. Now surgeons at University of Illinois Chicago Heath who have pioneered the use of robotic-assisted surgery has shown that robotic-assisted kidney transplant and bariatric surgery can be performed safely to successfully reduce surgical complications.
Reducing the level of body fat and waist size are linked to a lower risk of heart failure in patients with type 2 diabetes, according to a study led by UT Southwestern researchers. The findings, published in Circulation, suggest that all weight loss is not equal when it comes to mitigating the risk of heart disease.
Scientists from Indiana University School of Medicine, the University of Michigan and Case Western Reserve University have found that insulin has met an evolutionary cul-de-sac, limiting its ability to adapt to obesity and thereby rendering most people vulnerable to type 2 diabetes.
Synlogic has treated the first healthy volunteer in its Phase 1 study of the investigational Synthetic Biotic medicine SYNB8802 for the treatment of Enteric Hyperoxaluria (HOX). Enteric Hyperoxaluria is an acquired metabolic disorder caused by increased absorption of dietary oxalate, which is present in many healthy foods, making it almost impossible to control with diet alone.